by
(Reuters) - The World Health Organization on Monday was cautious about endorsing the use of recovered COVID-19 patients' plasma to treat people who are ill, saying evidence it works remains "low quality" even as the United States issued emergency authorization for such therapies.
"There are a number of clinical trials going on around the world looking at convalescent plasma compared to the standard of care," Soumya Swaminathan, WHO chief scientist, said.
"Only a few of them have actually reported interim results...and at the moment, it's still very low-quality evidence," she told a news conference.
(Reporting by John Miller in Zurich, Stephanie Nebehay in Geneva, Kate Kelland in London; Editing by Jon Boyle)
"who" - Google News
August 24, 2020 at 06:52PM
https://ift.tt/3jaiieO
WHO cautious on COVID-19 plasma as U.S. issues emergency authorization - WHTC News
"who" - Google News
https://ift.tt/36dvnyn
https://ift.tt/35spnC7
Bagikan Berita Ini
0 Response to "WHO cautious on COVID-19 plasma as U.S. issues emergency authorization - WHTC News"
Post a Comment